Key Market Indicators
By 2026, the death rate from New Zealand Influenza is predicted to rise to 72 fatalities. This is an average increase of 2.7% each year, starting from the 61 deaths recorded in 2021. Since 1965, the demand for New Zealand Influenza has grown annually by 5.4%. In 2021, New Zealand was ranked 30th in the world for Influenza deaths, with Estonia in the lead at 61 fatalities. Japan, Germany, and Canada followed in the rankings at numbers 2, 3, and 4 respectively.
New Zealand Infectious Disease Market Data and Forecasts
How much will New Zealand Infectious Disease Market grow to 2026?
Improve your Knowledge with the latest Indicators and Trends
The landscape of Herpesviruses (HHV) 4 and 5 infections, widely known as Epstein-Barr Virus (EBV) and Cytomegalovirus (CMV) respectively, has experienced significant changes in the recent past. Challenges in developing effective treatments have led to a heightened focus on research, with several new drugs in the pipeline. Current attention has...Read more
Growing demands for more effective treatments in response to the expanding global tuberculosis (TB) burden have marked the present landscape of the TB drugs market. Constant advancements in research and development have led to the introduction of novel products, while the presence of robust distribution networks facilitates reach to global...Read more
The Influenza A virus market segment remains essential, due to the recurrent need for effective vaccines and treatments. The industry is marked by iterative advancements, where prevailing therapeutic strategies are often displaced by newer ones. This is necessitated by the virus's propensity for mutation, a factor that underlines the importance...Read more
In terms of diagnostic technologies for infectious diseases, the landscape presents as ever-evolving. Suppliers are constantly engaged in the development and refinement of detection techniques, targeting early identification of a broad spectrum of infections. These innovations play a vital role in patient treatment and long-term disease management within all healthcare...Read more
The infectious disease market is evolving in response to ongoing public health challenges, such as the COVID-19 pandemic. This market features various sectors focusing on the development and distribution of vaccines, antivirals, antibiotics, and diagnostic tests. Market growth is primarily driven by factors such as increased incidences of infectious diseases,...Read more